Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students (VR-BodySafe)

12 november 2026 bijgewerkt door: Edanur Tar Bolacali, Kirsehir Ahi Evran Universitesi

The Effect of Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students on Awareness, Diagnosis and Reporting Attitudes: A Randomized Controlled Trial

The goal of this randomized controlled trial is to learn whether a virtual reality-supported child abuse and body safety education program improves fourth-year nursing students' awareness of child abuse and neglect, their ability to recognize its signs and risk factors, and their attitudes toward reporting it. The main questions it aims to answer are: - Do students who receive the program score higher in recognizing the signs and risks of child abuse and neglect than students who do not? - Do they have higher awareness of child abuse and neglect and more positive attitudes toward reporting child abuse? - Are these effects still present one month after the program ends? Researchers will compare an intervention group, which takes part in an 8-week face-to-face program (one 90-minute session per week) ending with a virtual reality simulation, with a control group that receives no training during the study. Control group students will be offered the same training after the study ends. Participants will: - Complete questionnaires before the program, after the program, and one month later - If assigned to the intervention group, attend weekly education sessions and take part in a short virtual reality simulation in week 8

Studie Overzicht

Toestand

Nog niet aan het werven

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

Background: Nurses are often the first health professionals to see signs of child abuse and neglect, but nursing students report limited knowledge, limited clinical exposure and uncertainty about legal reporting duties. Technology-based and simulation-based education may help close this gap. Design and setting: Two-arm, parallel-group, pretest-posttest randomized controlled trial with a one-month follow-up, conducted at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University, Kirsehir, Turkiye. The study was approved by the Cankiri Karatekin University Health Sciences Ethics Committee (Meeting No. 33, 12 May 2026) and is funded by the Kirsehir Ahi Evran University Scientific Research Projects Coordination Unit (SYO.A3.26.006). Reporting will follow the CONSORT 2025 statement. Sample size: Calculated with G*Power 3.1.9.2 using Child Abuse and Neglect Symptoms and Risk Diagnosis Scale scores from a similar study (3.39 +/- 0.28 and 3.60 +/- 0.28; effect size 0.75, alpha 0.05, power 0.95), giving 96 students (48 per group). Allowing for attrition, 100 students (50 per group) will be enrolled. Randomization and allocation concealment: After baseline measurements, students will be assigned 1:1 to the intervention or control group by simple randomization using a computer-generated sequence (randomizer.org). Randomization will be performed by an independent researcher not involved in delivering the intervention, and the allocation list will be concealed from the research team until assignment. Masking: Because of the nature of the intervention, participants and educators cannot be masked. Data will be coded (e.g., Group A and Group B) and analyzed by an independent statistician unaware of group allocation. Intervention delivery: Seven weekly face-to-face modules use active learning techniques. In week 8, students take part in the virtual reality game "Look From My World", in which they experience, from a 7-year-old child's point of view, a child's attempt to disclose a body safety violation to a school nurse and compare an inappropriate and an appropriate nursing response. The scenario does not depict abuse. A structured PEARLS debriefing follows. Module content and the scenario were reviewed by experts and will be pilot-tested with nursing students before the trial. Data analysis: IBM SPSS Statistics 29.0. Group x time effects will be tested with two-way repeated measures ANOVA when parametric assumptions are met, or with non-parametric equivalents. Analysis will follow the intention-to-treat principle. The significance level is set at p < 0.05. Safety: Participants may stop the virtual reality application at any time without any consequence. Students with epilepsy or severe motion sickness are excluded. Psychological support and referral information are available during and after the sessions.

Studietype

Ingrijpend

Inschrijving (Geschat)

100

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Fourth-year student at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University
  • Has completed the Child Health and Diseases Nursing (Pediatric Nursing) course
  • Has not previously attended a structured education program on child abuse and body safety
  • Volunteers to participate and signs the informed consent form
  • States that they can attend the education sessions and all measurements

Exclusion Criteria:

  • Has received certified training in child abuse, neglect or forensic nursing
  • Is actively working in an institution or project related to child abuse
  • Has a known health condition that may prevent virtual reality use (e.g., severe motion sickness or vertigo, epilepsy)
  • Did not complete the baseline measurements or completed the scales with substantial missing or invalid responses

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ander
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: VR-Supported Body Safety Education

Fourth-year nursing students who receive an 8-week face-to-face education program (one 90-minute session per week) on child abuse, neglect and body safety, ending with a virtual reality simulation in week 8.

An 8-week face-to-face program with one 90-minute session per week. Weeks 1-7 cover child maltreatment; child neglect and the nursing approach; types of child abuse (physical, emotional, sexual and cyber abuse); child abuse and the nursing approach, including documentation and legal reporting; interventions for preventing child abuse and neglect; and body safety education for teaching children self-protection skills (two sessions). Each module uses an active learning technique (station technique, six thinking hats, brainstorming, six action shoes, cooperative learning). In week 8, students complete the virtual reality game "Look From My World" (about 6 minutes), experiencing from a 7-year-old child's perspective a disclosure to a school nurse with an inappropriate and an appropriate nursing response, followed by a structured PEARLS debriefing.

Geen tussenkomst: Wait-list Control

Fourth-year nursing students who receive no training during the study and continue their usual curriculum. They will be offered the same program after the one-month follow-up measurement.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Recognition of Signs and Risks of Child Abuse and Neglect
Tijdsspanne: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Symptoms and Risk Diagnosis Scale (Uysal, 1998), 67 items in 6 subscales rated on a 5-point Likert scale (21 items reverse-scored). Total score ranges from 67 to 335; higher scores indicate better recognition of the signs and risk factors of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Child Abuse and Neglect Awareness
Tijdsspanne: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Awareness Scale, 20 case-based items in 4 subscales (physical, sexual and emotional abuse, and neglect) rated on a 5-point Likert scale. Total score ranges from 20 to 100; higher scores indicate greater awareness of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention
Attitudes Toward Reporting Child Abuse
Tijdsspanne: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Turkish version of the Healthcare Provider Attitudes Toward Child Maltreatment Reporting Scale (Singh et al., 2017; Turkish adaptation by Turan and Erdogan, 2019), 21 items rated on a 5-point Likert scale. Total score ranges from 21 to 105; higher scores indicate more positive, responsibility-oriented attitudes toward reporting child abuse.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

17 november 2026

Primaire voltooiing (Geschat)

15 januari 2027

Studie voltooiing (Geschat)

28 februari 2027

Studieregistratiedata

Eerst ingediend

12 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

12 november 2026

Eerst geplaatst (Werkelijk)

18 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

18 november 2026

Laatste update ingediend die voldeed aan QC-criteria

12 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • SYO.A3.26.006

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Individual participant data will not be shared because participants did not consent to data sharing and the dataset includes sensitive information about participants' own childhood experiences of abuse and neglect. Aggregate results will be published in a peer-reviewed journal.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .